| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Parsa Kiai is Director at MED. Parsa Kiai's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $257K at current prices.
Net of sales, the MED filings show accumulation of 125,523 shares.
Parsa Kiai has 5 Form 4 filings on record from May 2026 to October 2026, all as Director at Medifast (MED), 2026.
The 12 reported transactions were 10 open-market purchases and 2 stock awards.
Counted by filing, the open-market trades come to 4 purchases worth about $1.5M and no sales.
The largest open-market purchase was 72,487 shares of MED at an average $11.63 on August 20, 2026, about $843K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | MED Medifast, Inc. | Director | Buy | 5,557 | $12.24 | $68,027.13 | +37.4% | - | - | |
| Aug 26, 2026 | MED Medifast, Inc. | Director | Buy | 43,150 | $12.26 | $529,157.08 | -188.6% | - | - | |
| Aug 24, 2026 | MED Medifast, Inc. | Director | Buy | 4,329 | $12.00 | $51,946.27 | +29.3% | - | - | |
| Aug 20, 2026 | MED Medifast, Inc. | Director | Buy | 72,487 | $11.63 | $842,698.67 | -135.5% | - | - |